Statins cut major cardiovascular events by 30% in healthy adults over 70, STAREE trial finds
The landmark STAREE randomized trial found that atorvastatin reduced first major cardiovascular events by 30% among adults aged 70 and older without established cardiovascular disease, diabetes or dementia, potentially resolving a long-running treatment question for older patients.